Abstract:The entry of human immunodeficiency virus (HIV) into cells depends on a sequential interaction of the gp120 envelope glycoprotein with the cellular receptors CD4 and members of the chemokine receptor family. The CC chemokine receptor CCR5 is such a receptor for several chemokines and a major coreceptor for the entry of R5 HIV type-1 (HIV-1) into cells. Although many studies focus on the interaction of CCR5 with HIV-1, the corresponding interaction sites in CCR5 and gp120 have not been matched. Here we used an approach combining protein structure modeling, docking and molecular dynamics simulation to build a series of structural models of the CCR5 in complexes with gp120 and CD4. Interactions such as hydrogen bonds, salt bridges and van der Waals contacts between CCR5 and gp120 were investigated. Three snapshots of CCR5–gp120–CD4 models revealed that the initial interactions of CCR5 with gp120 are involved in the negatively charged N-terminus (Nt) region of CCR5 and positively charged bridging sheet region of gp120. Further interactions occurred between extracellular loop2 (ECL2) of CCR5 and the base of V3 loop regions of gp120. These interactions may induce the conformational changes in gp120 and lead to the final entry of HIV into the cell. These results not only strongly support the two-step gp120–CCR5 binding mechanism, but also rationalize extensive biological data about the role of CCR5 in HIV-1 gp120 binding and entry, and may guide efforts to design novel inhibitors. Figure Three structural models of CCR5 in complex with gp120–CD4. These represent snapshots of different intermediates of the complex that characterize the dynamic interaction process of CCR5 with gp120. The ribbon diagram shows gp120 in red , the two N-terminal domains of CD4 in yellow , and CCR5 in blue . The Nt, ECL1, 2, and 3 in CCR5, as well as the bridging sheet and V3 loop base of gp120 are labeled. Model I shows that Nt begins to interact with the bridging sheet, the ECLs of CCR5 do not interact with gp120 and there is a big gap between them. It is a snapshot of the initial recognition of CCR5 with gp120. Model III shows that ECL2 begins to interact with the V3 loop base in addition to the interaction between Nt and the bridging sheet. It is a snapshot of the transition state of the binding process. Model II shows the full interaction between CCR5 and gp120. More residues within Nt interact with the bridging sheet, ECL2 and ECL3 interact with the V3 base loop and bridging sheet, respectively. It is a snapshot of a "fusion-active" state prior to virus entry. The interaction intensities between CCR5 and gp120 are model I<model III<model II

Molecular Motions of Human HIV-1 Gp120 Envelope Glycoproteins

Molecular Motions and Conformational Transition Between Different Conformational States of HIV-1 Gp120 Envelope Glycoprotein

Insight Derived from Molecular Dynamics Simulations into Molecular Motions, Thermodynamics and Kinetics of HIV-1 Gp120

Dynamic Domains and Geometrical Properties of HIV-1 Gp120 During Conformational Changes Induced by CD4 Binding

Molecular Motions in Hiv-1 Gp120 Mutants Reveal Their Preferences for Different Conformations

Molecular Dynamics Simulations Reveal Distinct Differences in Conformational Dynamics and Thermodynamics Between the Unliganded and CD4-bound States of HIV-1 Gp120.

CD4-binding obstacles in conformational transitions and allosteric communications of HIV gp120

Effects Of Cd4 Binding On Conformational Dynamics, Molecular Motions, And Thermodynamics Of Hiv-1 Gp120

The Molecular Mechanism of Two Coreceptor Binding Site Antibodies X5 and 17b Neutralizing HIV-1: Insights from molecular dynamics simulation.

Characterization of the conformational state and flexibility of HIV-1 glycoprotein gp120 core domain.

The Glycan‐mediated Mechanism on the Interactions of Gp120 with CD4 and Antibody: Insights from Molecular Dynamics Simulation

Insights into the Molecular Mechanism Underlying CD4-dependency and Neutralization Sensitivity of HIV-1: a Comparative Molecular Dynamics Study on Gp120s from Isolates with Different Phenotypes

Structural and functional characterization of the human CCR5 receptor in complex with HIV gp120 envelope glycoprotein and CD4 receptor by molecular modeling studies

Understanding of the Bridging Sheet Formation of HIV-1 Glycoprotein Gp120.

Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody

Theoretical Studies on the Interactions and Interferences of HIV-1 Glycoprotein Gp120 and Its Coreceptor CCR5

Residues in the Gp41 Ectodomain Regulate HIV-1 Envelope Glycoprotein Conformational Transitions Induced by Gp120-Directed Inhibitors.

Understanding the molecular mechanism of the broad and potent neutralization of HIV-1 by antibody VRC01 from the perspective of molecular dynamics simulation and binding free energy calculations

Conformation of trimeric envelope glycoproteins: the CD4-dependent membrane fusion mechanism of HIV-1

Characterize Dynamic Conformational Space of Human CCR5 Extracellular Domain by Molecular Modeling and Molecular Dynamics Simulation

Patterns of Conserved Gp120 Epitope Presentation on Attached HIV-1 Virions.